Stocks Health care TVGN
NASDAQ · Health careTevogen Inc. (TVGN)
It posted a net loss of $21.6M. In fiscal 2025 capital spending exceeded operating cash flow by $12.4M. At June 30, 2026 it held $1.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about Tevogen Inc.
- Net worth
- Tevogen Inc. has a market value (market cap) of $38M at the latest share price, and shareholders' equity of -$8.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $12.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Tevogen Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Tevogen Inc. does
Tevogen Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker TVGN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$26.3M | -$8.08 | -$12.4M |
| 2024 | n/a | -$13.7M | -$3.50 | n/a |
| 2023 | n/a | -$60.5M | -$122.00 | -$8.3M |
| 2022 | n/a | $4.4M | n/a | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Tevogen Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 30, 2026Other event 8-K
- September 16, 2026Activist stake changed SCHEDULE 13D/A
- September 16, 2026Activist stake changed SCHEDULE 13D/A
- September 16, 2026
- September 10, 2026Other event 8-K
- August 26, 2026
- August 24, 2026
- August 14, 2026
- August 3, 2026Proxy statement DEF 14A
- July 30, 2026
Insider trades
What the people running Tevogen Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 7 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 14, 2026 | Desai KirtiChief Financial Officer | Received as pay | 750,000 | - |
| September 14, 2026 | Saadi Ryan H.Chief Executive Officer, Director, 10% owner | Received as pay | 8,000,000 | - |
| September 11, 2026 | Patton Curtis L.Director | Received as pay | 75,000 | - |
| September 11, 2026 | Feike Jeffrey L.Director | Received as pay | 75,000 | - |
| September 11, 2026 | Sordillo Victor J.Director | Received as pay | 75,000 | - |
| September 11, 2026 | Podlogar Susan MDirector | Received as pay | 75,000 | - |
| September 11, 2026 | Goh Keow LinDirector | Received as pay | 75,000 | - |
| July 10, 2026 | Desai KirtiChief Financial Officer | Received as pay | 40,000 | - |
Who owns TVGN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Saadi Ryan H.13D, may seek influence | 74.4% | September 16, 2026 |
| Ryan H. Saadi13D, may seek influence | 71.9% | February 22, 2024 |
| Kirti Desai13D, may seek influence | 6.3% | September 16, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 31 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Vanguard Capital Management LLC | 23,976 | -9,272 |
| Morgan Stanley | 18,809 | +1,475 |
| Aqr Capital Management LLC | 17,237 | new |
| Goldman Sachs Group Inc | 14,163 | new |
| Jane Street Group, LLC | 11,175 | new |
| Fmr LLC | 9,826 | -331 |
| Russell Investments Group, Ltd. | 6,532 | +726 |
| Tower Research Capital LLC (TRC) | 1,494 | +553 |
| UBS Group AG | 1,083 | -2,484 |
| Vanguard Fiduciary Trust Co | 838 | -530 |
| GAMMA Investing LLC | 762 | +622 |
| Jpmorgan Chase & Co | 393 | -86 |
| Arax Advisory Partners | 401 | new |
| Royal Bank of Canada | 154 | +33 |
| Integrated Wealth Concepts LLC | 171 | new |
| Bnp Paribas Financial Markets | 121 | -161 |
| Citigroup Inc | 61 | +18 |
| Allworth Financial LP | 50 | new |
| Nisa Investment Advisors, LLC | 48 | new |
| Barclays PLC | 33 | -216 |
Insiders
8 insiders reported holding 13,420,134 shares in total, about $78.4M at the last price.
| Holder | Shares |
|---|---|
| Saadi Ryan H.Chief Executive Officer, Director, 10% owner | 11,705,689 |
| Desai KirtiChief Financial Officer | 992,983 |
| Patton Curtis L.Director | 139,192 |
| Feike Jeffrey L.Director | 131,435 |
| Sordillo Victor J.Director | 126,539 |
| Podlogar Susan MDirector | 123,678 |
| Goh Keow LinDirector | 123,678 |
| Flomenberg NealSee Remarks | 76,940 |
Questions about TVGN
What does Tevogen Inc. do?
Tevogen Inc. is a company in the Health care sector, listed on NASDAQ as TVGN. Its shares trade on NASDAQ under the ticker TVGN.
What is Tevogen Inc.'s net worth?
Tevogen Inc. has a market value (market cap) of $38M at the latest share price, and shareholders' equity of -$8.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Tevogen Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $21.6M.
When did Tevogen Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 30, 2026.
When is Tevogen Inc.'s next earnings report?
Tevogen Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare TVGN with
Follow TVGN
Get an email when Tevogen Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Tevogen Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.